Elevance Health(ELV) - 2025 Q1 - Earnings Call Presentation

Financial Performance - Operating revenue reached $488 billion, a 154% increase[7, 8, 10] - Health Benefits operating revenue was $41431 billion, up 112%[12, 35] - CarelonRx operating revenue was $167 billion, a 254% increase[16, 35] - Carelon Services operating revenue increased by 630% to $6536 billion[17, 35] - Adjusted operating expense improved by 60 bps[10] - Adjusted diluted earnings per share are targeted to grow at least 12% annually[21, 22, 26] Health Benefits Segment - Health Benefits membership totaled 458 million, a decrease of 05%[12, 15] - Adjusted operating margin for Health Benefits declined by 80 bps to 54%[15] Carelon Segment - Carelon Services operating revenue expanded by over 60%[17] - Adjusted scripts in CarelonRx increased by 90%[16]